News & Publications

Our Blog

Welcome to the Cancer Research Institute blog. Here we share the latest updates on the field of cancer immunotherapy from CRI, including scientific breakthroughs, news stories, and program announcements. We invite your comments and encourage you to share these stories with your friends.

You can receive notifications of new posts by subscribing to our blog. Just click the RSS icon in the upper right corner.

Merck’s PD-1 Drug Outperforms Ipilimumab for Treatment of Advanced Melanoma

March 24, 2015

Matthew Tontonoz

Data from a phase III trial indicate that Keytruda stands ready to become standard-of-care for advanced melanoma.

checkpoint-inhibitor, ipilimumab, melanoma

Blog Archives

March 2017(2)
February 2017(3)
January 2017(2)
December 2016(6)
November 2016(3)
October 2016(6)
September 2016(8)
August 2016(3)
July 2016(6)
June 2016(20)
May 2016(8)
April 2016(12)
March 2016(4)
February 2016(7)
January 2016(4)
December 2015(9)
November 2015(5)
October 2015(6)
September 2015(10)
August 2015(4)
July 2015(6)
June 2015(5)
May 2015(9)
April 2015(13)
March 2015(8)
February 2015(6)
January 2015(6)
December 2014(10)
November 2014(5)
October 2014(8)
September 2014(7)
August 2014(7)
July 2014(6)
June 2014(8)
May 2014(10)
April 2014(8)
March 2014(13)
February 2014(8)
January 2014(12)
December 2013(9)
November 2013(5)
October 2013(11)
September 2013(4)
August 2013(5)
July 2013(4)
June 2013(4)
May 2013(5)
April 2013(3)
March 2013(8)
February 2013(1)
December 2012(3)
December 2011(1)
November 2009(1)
February 2009(1)

Our Bloggers


30 Days AACR AIDS animals annual report antibody anti-CTLA-4 antigens anti-PD-1 ASCO autoimmune disease awards & honors awareness bacteria bequests bispecific antibodies bladder cancer blood cancers bone cancer brain cancer Breakthrough Therapy breast cancer cancer Cancer Immunity Cancer Immunology Research cancer immunotherapy Cancer Immunotherapy Consortium cancer immunotherapy month cancer moonshot cancer research CAR T cell therapy caregivers cervical cancer charity checkpoint blockade checkpoint inhibitor checkpoint-inhibitor chemotherapy childhood cancer clinical accelerator clinical trials Coley's toxins collaboration colorectal cancer combination therapy community community fundraising CTLA-4 donate dream team drug emma whitehead employer matching gifts epigenetics event events experimental FDA FDA approval fellows flu gene therapy givingtuesday grants head and neck cancer herceptin history HIV immune system immunotherapy in the news innovation Inspire interview ipilimumab James Allison Jedd Wolchok kidney cancer leukemia lloyd old lung cancer lymphoma marathon melanoma multiple myeloma NBC Nightly News obituary ovarian cancer pancreatic cancer patients PD-1 planned giving postdocs prevention progress promotion prostate cancer publication research awards ride to conquer cancer scientific leadership skin cancer stomach cancer support group survival T cell T cell therapy Team CRI Through the Kitchen timeline twitter vaccine webinar website white out cancer yervoy young philanthropists